In the corresponding quarter of the previous fiscal, KEC International posted a net profit of ₹96.9 crore, the company said ...

Q3 2025 Earnings Call Transcript January 30, 2025 Takeshi Horikoshi: This is Horikoshi, the CFO. I will go through the ...

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

Infrastructure developer Welspun Enterprises on Monday reported a 4 per cent fall in its consolidated profit after tax to Rs ...

Generic injectables maker Gland Pharma on February 3 reported a 7% rise in third-quarter profit, as lower expenses helped ...

The EBITDA margin stood at 26% in the reporting quarter versus 23.1% YoY. The results came after the close of the market ...

Alembic's revenue from operations rose to Rs 1,692.74 crore in Q3FY25, a 3.8 per cent Y-o-Y increase from Rs 1,630.57 crore ...

Titan’s revenue from operations in Q3FY25 is estimated to grow 25% YoY, while its net profit is expected to remain flat due ...

Sundaram Finance reported a 16% YoY rise in Q3 net profit to Rs 349 crore and a 22% increase in revenue to Rs1,648 crore.

The company's revenue from operations increased 3 percent to Rs 11,550 crore as against Rs 11,233 crore in the corresponding ...

India's Divi's Laboratories reported a better-than-expected quarterly profit on Monday, aided by strong performance of its business that focuses on customised production of chemical compounds used in ...

Indian drugmaker Alembic Pharmaceuticals reported a lower third-quarter profit on Monday, weighed down by weak local sales of its drugs that treat acute illnesses.